Prognostic factors in multiple myeloma: role of ?2-microglobulin and thymidine kinase
- 1 November 1993
- journal article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 71 (11)
- https://doi.org/10.1007/bf00185604
Abstract
Serum β2- microglobulin, serum thymidine kinase, and commonly used prognostic parameters were investigated for their prognostic value in a well-defined group of patients with multiple myeloma (n = 207). Multivariate analysis showed hemoglobin to be the parameter of strongest prognostic value. Only albumin, serum β2-microglobulin and serum thymidine kinase added further prognostic information. When tested for efficiency in recognizing patients with poor (average survival time < 1 year) and good (average survival time > 5 years) prognosis, serum β2-microglobulin was best (80%), followed by total urinary protein (78%), hemoglobin (76%), and albumin (75%).Keywords
This publication has 0 references indexed in Scilit: